SD:
1) Journal of Pharmaceutical and Biomedical Analysis
Volume 47, Issue 3, 15 July 2008, Pages 631-635
Non-destructive quantitative analysis of risperidone in film-coated tablets
M.G. Orkoulaa, b and C.G. Kontoyannis
Код: Выделить всё
http://dx.doi.org/10.1016/j.jpba.2008.01.049Volume 40, Issue 3, 24 February 2006, Pages 598-604
Structural studies of impurities of risperidone by hyphenated techniques
P. Sattanathana, J. Moses Babu
Код: Выделить всё
http://dx.doi.org/10.1016/j.jpba.2005.10.034Volume 36, Issue 1, 21 September 2004, Pages 231-235
Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms
Rajesh Singh Tomar, T. J. Joseph, A. S. R. Murthy, D. V. Yadav, G. Subbaiah and K. V. S. R. Krishna Reddy
Код: Выделить всё
http://dx.doi.org/10.1016/j.jpba.2004.05.022Volume 36, Issue 5, 4 January 2005, Pages 975-981
High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets
Zeinab A. El-Sherif
Код: Выделить всё
http://dx.doi.org/10.1016/j.jpba.2004.07.014Volume 783, Issue 2, 15 January 2003, Pages 461-472
Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography–tandem mass spectrometry
B. M. M. Remmerie
Код: Выделить всё
http://dx.doi.org/10.1016/S1570-0232(02)00715-86) Journal of Separation Science
Volume 28 Issue 3, Pages 245 - 250
HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes
Maria Augusta Raggi
Код: Выделить всё
dx.doi.org/10.1002/jssc.200401939